High Levels of Persistent Expression of α1-Antitrypsin Mediated by the Nonhuman Primate Serotype rh.10 Adeno-associated Virus Despite Preexisting Immunity to Common Human Adeno-associated Viruses
Open Access
- 31 January 2006
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 13 (1), 67-76
- https://doi.org/10.1016/j.ymthe.2005.09.003
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Intrapleural administration of a serotype 5 adeno-associated virus coding for α1-antitrypsin mediates persistent, high lung and serum levels of α1-antitrypsinMolecular Therapy, 2004
- Immune responses to gene therapy vectors: influence on vector function and effector mechanismsGene Therapy, 2004
- Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene TransferJournal of Virology, 2001
- Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)Journal of Medical Virology, 1999
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.JCI Insight, 1990
- The Alpha1-antitrypsin Gene and Its MutationsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1989
- Molecular basis of alpha-1-antitrypsin deficiencyAmerican Journal Of Medicine, 1988
- Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirusVirology, 1984
- HUMAN PLASMA PROTEINASE INHIBITORSAnnual Review of Biochemistry, 1983